NOT-TR-21-018: Notice of Termination of RFA-TR-20-030 "Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Not Allowed)

Notice of Termination of RFA-TR-20-030 "Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Not Allowed)”

Notice Number:

NOT-TR-21-018

Key Dates

Release Date:

January 25, 2021

Related Announcements

RFA-TR-20-030 - Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Not Allowed)

RFA-TR-21-008 - Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Optional)

Issued by

National Center for Advancing Translational Sciences (NCATS)

Purpose

Effective immediately, the Funding Opportunity Announcement RFA-TR-20-030 "Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Not Allowed)" is terminated. Applications submitted to RFA-TR-20-030 will not be reviewed. NIH has reissued this Funding Opportunity Announcement as RFA-TR-21-008 "Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Optional)."

Inquiries

Please direct all inquiries to:

Alice Chen Grady, MD
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-827-2015
Email: [email protected]